Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Griseofulvin 75mg/5ml oral suspension
0502050B0AABVBV
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 80mg/5ml oral suspension
0502050B0AABIBI
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 85mg/5ml oral suspension
0502050B0AACECE
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 90mg/5ml oral suspension
0502050B0AAAYAY
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Grisovin 125mg tablets
0502050B0BCAAAB
|
Grisovin | Griseofulvin | Infections | No data available |
|
Grisovin 500mg tablets
0502050B0BCABAC
|
Grisovin | Griseofulvin | Infections | No data available |
|
Hepsera 10mg tablets
0503031A0BBAAAA
|
Hepsera | Adefovir dipivoxil | Infections | No data available |
|
Hivid 375microgram tablets
0503010X0BBABAB
|
Hivid | Zalcitabine | Infections | No data available |
|
Hivid 750microgram tablets
0503010X0BBAAAA
|
Hivid | Zalcitabine | Infections | No data available |
|
Humatin 125mg/5ml oral solution
0504050T0BBACAC
|
Humatin | Paromomycin sulfate | Infections | No data available |
|
Ictastan 200mg/245mg tablets
0503010AABCAAAA
|
Ictastan | Emtricitabine and tenofovir disoproxil | Infections | No data available |
|
Imipenem 500mg / Cilastatin 500mg inf vials
0501022D0AAAAAA
|
Imipenem/cilastatin sodium | Imipenem with cilastatin | Infections | No data available |
|
Imipenem 500mg / Cilastatin 500mg inj vials
0501022D0AAACAC
|
Imipenem/cilastatin sodium | Imipenem with cilastatin | Infections | No data available |
|
Incivo 375mg tablets
0503032B0BBAAAA
|
Incivo | Telaprevir | Infections | No data available |
|
Indinavir 100mg capsules
0503010T0AAADAD
|
Indinavir | Indinavir | Infections | No data available |
|
Indinavir 200mg capsules
0503010T0AAABAB
|
Indinavir | Indinavir | Infections | No data available |
|
Indinavir 333mg capsules
0503010T0AAACAC
|
Indinavir | Indinavir | Infections | No data available |
|
Indinavir 400mg capsules
0503010T0AAAAAA
|
Indinavir | Indinavir | Infections | No data available |
|
Intelence 100mg tablets
0503010AFBBAAAA
|
Intelence | Etravirine | Infections | No data available |
|
Intelence 200mg tablets
0503010AFBBABAB
|
Intelence | Etravirine | Infections | No data available |
|
Intelence 25mg tablets
0503010AFBBACAC
|
Intelence | Etravirine | Infections | No data available |
|
Invanz 1g powder for solution for infusion vials
0501022B0BBAAAA
|
Invanz | Ertapenem sodium | Infections | No data available |
|
Invirase 200mg capsules
0503010R0BBAAAA
|
Invirase | Saquinavir mesylate | Infections | No data available |
|
Invirase 500mg tablets
0503010R0BBABAB
|
Invirase | Saquinavir mesylate | Infections | No data available |
|
Isentress 100mg chewable tablets
0503010AEBBABAB
|
Isentress | Raltegravir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.